— Know what they know.
Not Investment Advice

IDYA NASDAQ

IDEAYA Biosciences, Inc.
1W: +2.4% 1M: -6.7% 3M: -7.6% YTD: -12.7% 1Y: +50.5% 3Y: +38.3% 5Y: +51.4%
$29.10
-0.44 (-1.49%)
 
Weekly Expected Move ±5.1%
$25 $27 $28 $30 $31
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 46 · $2.6B mcap · 87M float · 1.35% daily turnover · Short 68% of daily vol

📊 Key Metrics

TTM
$225M
Revenue
+3118.1% YoY
$-140M
Net Income
+54.4% YoY
$-88M
Free Cash Flow
+67.2% YoY
82.6%
Gross Margin
-1654.6%
Op. Margin
-1502.1%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-13.5%
ROA-12.5%
ROIC-35.2%

Valuation

P/E-18.4
P/B2.8
EV/EBITDA-15.0

Leverage

Debt/Equity0.03
Current Ratio11.34
Interest Cov.0.0x

Quality Scores

Piotroski F3/9
Altman Z19.98
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms